Information
This is achieved through modern diagnostic methods (cytodiagnostics, colposcopy, targeted biopsy) and the collaborative work of gynecologists, cytologists, and histologists.
Cervical cancer is one of the most common malignant diseases in women and is a leading oncological cause of their mortality. Every year in our country more than 700 women get sick and more than 200 die, between the ages of 30 and 50. Risk groups include women with early sexual activity; women who frequently change sexual partners; women with sexually transmitted diseases, with infection with HPV - human papillomavirus being particularly dangerous.
The favorable aspect of this type of cancer is that it never arises on healthy tissue, but begins its development gradually, preceded by a number of stages - the so-called precancerous conditions (known among women as "sores"). By diagnosing and treating precancerous conditions, the chain leading to the development of cervical cancer is interrupted, i.e. 100% prevention of carcinogenesis.
Precancerous changes are asymptomatic, without complaints. Cancer also has no early symptoms. The first symptoms, such as contact bleeding, are already late symptoms. Pain and urosepsis appear at an advanced stage of the malignant process.
The diagnosis of precancerous changes and their treatment is quick, painless, and financially accessible. At the Obstetrics and Gynecology Office of DCC VITA, opportunistic screening is used: every gynecological examination is also an oncoprophylactic one, which means that a preventive Pap smear is taken from every woman, regardless of the reason for the visit to the gynecologist. The optimal interval for preventive Pap smears is 6-12 months.
On this page, you can change your choices at any time after you have read and understood our